SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-081521
Filing Date
2024-07-03
Accepted
2024-07-03 16:15:05
Documents
1
Period of Report
2024-07-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4120
  Complete submission text file 0000950170-24-081521.txt   5642
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FLAGSHIP PIONEERING, INC. 55 CAMBRIDGE PARKWAY, STE 800E CAMBRIDGE MA 02139
Business Address
Berenson Stephen (Reporting) CIK: 0001760671 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 241100288